KARAGEOZIAN HAMPAR 4

4 · VIRAL GENETICS INC /DE/ · Filed Oct 22, 2004

Form 4

Period: 2004-08-05

Director10% Owner

Transactions

Award
stock option
2004-09-20+99,858→ 99,858 total
Exercise: $0.52Exp: 2006-09-19→ common stock (99,858 underlying)
Gift
common stock
2004-09-29−100,000→ 10,276,221 total
Other
convertible note
2004-08-05
Exercise: $0.30Exp: 2008-05-31→ common stock (2,759,728 underlying)
Award
common stock
2004-09-20+4,934,712→ 10,276,221 total
Award
common stock warrant
2004-09-20+4,934,712→ 4,934,712 total
Exercise: $0.40Exp: 2009-09-19→ common stock (4,934,712 underlying)
Award
stock option
2004-09-20+49,929→ 49,929 total
Exercise: $0.38Exp: 2006-09-19→ common stock (49,929 underlying)

Footnotes (8)

[F1]gifted to child
[F2]the high bid price of the common stock of Viral Genetics, Inc., on the over-the-counter market on the date of gifting was $0.44
[F3]Received in exchange for capital stock of Therapeutic Genetic, Inc., in connection with merger of Therapeutic Genetic, Inc. into subsidiary of Viral Genetics, Inc. On September 20, 2004, the high bid price for Viral Genetics, Inc. common stock in the over-the-counter market was $0.38.
[F4]note assigned to Best Investments, Inc.
[F5]immediately
[F6]not applicable
[F7]The warrants were issued with the common stock of Viral Genetics, Inc., in the merger transaction that resulted in the acquisition of Therapeutic Genetic, Inc.
[F8]All stock options with a transaction date of 09/20/2004 are options originally granted to Therapeutic Genetic, Inc. and distributed by Therapeutic Genetic, Inc. to its shareholders for no consideration immediately prior to the merger of Therapeutic Genetic, Inc. with the subsidiary of Viral Genetics, Inc.

Documents

1 file